Assessment of Bronchial Asthma Among Patients Attending Sohag University Hospital
- Conditions
- Bronchial Asthma
- Interventions
- Drug: corticosteroids
- Registration Number
- NCT06141161
- Lead Sponsor
- Sohag University
- Brief Summary
Asthma is a significant public health threat, affecting more than 300 million individuals globally. Asthma is classified as a non-communicable disease and leads to reduced quality of life, poor physical functioning and reduced emotional well-being. The impact of this disease can be widespread and extends beyond the person living with the disease, affecting the lives of their family members, carers, communities and the health care system (1).
Asthma is a variable chronic respiratory condition. It is characterized by symptoms of wheeze, cough, chest tightness, dyspnea and backed by variable airflow limitation, airway inflammation and airway hyper-responsiveness (AHR). The severity of asthma varies considerably, both between individuals and within individuals over time. Some people may have intermittent asthma and others may experience severe, potentially life-threatening disease (2, 3,4).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200
- bronchial asthma patients aged more than 18 years, both sexes are included
- children ,patients who are unable to do spiromerty or contrindecated
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description group B corticosteroids group B(uncontrolled bronchial asthma patients) group A, corticosteroids group A (controlled bronchial asthma patients)
- Primary Outcome Measures
Name Time Method percent of controlled bronchial asthma patients 12 months to detect percent of controlled patients
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sohag University hospitals
🇪🇬Sohag, Egypt